Price
CHART BY
Frequently asked questions
What is DaVita's market capitalization?
What is DaVita's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for DaVita?
What are the analyst ratings and target price for DaVita's stock?
What is DaVita's revenue over the trailing twelve months?
What is the EBITDA for DaVita?
What is the free cash flow of DaVita?
How many employees does DaVita have, and what sector and industry does it belong to?
What is the free float of DaVita's shares?
Financials
- Market Cap
- $13.94B
- EPS (TTM)
- $9.276
- Free Float
- 78.32M
- P/E ratio (TTM)
- 18.32
- Revenue (TTM)
- $12.67B
- EBITDA (TTM)
- $2.63B
- Free Cashflow (TTM)
- $1.42B
Pricing
- 1D span
- $167.82$170.76
- 52W span
- $103.56$170.29
Analyst Ratings
The price target is $163.00 and the stock is covered by 11 analysts.
Buy
1
Hold
8
Sell
2
Information
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
- Employees
- 70,000
- Industries
- Medical/Nursing Services
- Sector
- Health Care
Identifier
- ISIN
- US23918K1088
- Primary Ticker
- DVA